BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 28078507)

  • 1. Quantitative analysis of diffusion-weighted magnetic resonance images: differentiation between prostate cancer and normal tissue based on a computer-aided diagnosis system.
    Gao G; Wang C; Zhang X; Hu J; Yang X; Wang H; Zhang J; Wang X
    Sci China Life Sci; 2017 Jan; 60(1):37-43. PubMed ID: 28078507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proposed Adjustments to PI-RADS Version 2 Decision Rules: Impact on Prostate Cancer Detection.
    Rosenkrantz AB; Babb JS; Taneja SS; Ream JM
    Radiology; 2017 Apr; 283(1):119-129. PubMed ID: 27783538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DWI of the prostate: Comparison of a faster diagonal acquisition to standard three-scan trace acquisition.
    Corcuera-Solano I; Wagner M; Hectors S; Lewis S; Titelbaum N; Stemmer A; Rastinehad A; Tewari A; Taouli B
    J Magn Reson Imaging; 2017 Dec; 46(6):1767-1775. PubMed ID: 28301097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Weighted Diffusion Subtraction for Detection of Clinically Significant Prostate Cancer.
    Sato T; Isoda H; Fujimoto K; Furuta A; Fujimoto M; Ito K; Kobayashi T; Nakamoto Y
    J Magn Reson Imaging; 2021 Dec; 54(6):1979-1988. PubMed ID: 34085328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PI-RADS Versions 2 and 2.1: Interobserver Agreement and Diagnostic Performance in Peripheral and Transition Zone Lesions Among Six Radiologists.
    Bhayana R; O'Shea A; Anderson MA; Bradley WR; Gottumukkala RV; Mojtahed A; Pierce TT; Harisinghani M
    AJR Am J Roentgenol; 2021 Jul; 217(1):141-151. PubMed ID: 32903060
    [No Abstract]   [Full Text] [Related]  

  • 6. Diagnostic efficacy of b value (2000 s/mm
    Ma S; Xu K; Xie H; Wang H; Wang R; Zhang X; Wei J; Wang X
    Eur J Radiol; 2018 Oct; 107():125-133. PubMed ID: 30292256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate Cancer Differentiation and Aggressiveness: Assessment With a Radiomic-Based Model vs. PI-RADS v2.
    Chen T; Li M; Gu Y; Zhang Y; Yang S; Wei C; Wu J; Li X; Zhao W; Shen J
    J Magn Reson Imaging; 2019 Mar; 49(3):875-884. PubMed ID: 30230108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate Cancer Detection with Multiparametric Magnetic Resonance Imaging: Prostate Imaging Reporting and Data System Version 1 versus Version 2.
    Feng ZY; Wang L; Min XD; Wang SG; Wang GP; Cai J
    Chin Med J (Engl); 2016 Oct; 129(20):2451-2459. PubMed ID: 27748338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diffusion-weighted imaging in the assessment of prostate cancer: Comparison of zoomed imaging and conventional technique.
    Brendle C; Martirosian P; Schwenzer NF; Kaufmann S; Kruck S; Kramer U; Notohamiprodjo M; Nikolaou K; Schraml C
    Eur J Radiol; 2016 May; 85(5):893-900. PubMed ID: 27130048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triexponential function analysis of diffusion-weighted MRI for diagnosing prostate cancer.
    Ueda Y; Takahashi S; Ohno N; Kyotani K; Kawamitu H; Miyati T; Aoyama N; Ueno Y; Kitajima K; Kawakami F; Okuaki T; Tsukamoto R; Yanagita E; Sugimura K
    J Magn Reson Imaging; 2016 Jan; 43(1):138-48. PubMed ID: 26119033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of interreader reproducibility of the prostate imaging reporting and data system and likert scales for evaluation of multiparametric prostate MRI.
    Rosenkrantz AB; Lim RP; Haghighi M; Somberg MB; Babb JS; Taneja SS
    AJR Am J Roentgenol; 2013 Oct; 201(4):W612-8. PubMed ID: 24059400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DCE-MRI of the prostate using shutter-speed vs. Tofts model for tumor characterization and assessment of aggressiveness.
    Hectors SJ; Besa C; Wagner M; Jajamovich GH; Haines GK; Lewis S; Tewari A; Rastinehad A; Huang W; Taouli B
    J Magn Reson Imaging; 2017 Sep; 46(3):837-849. PubMed ID: 28092414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic performance of diffusion-weighted imaging for prostate cancer: Peripheral zone versus transition zone.
    Lee H; Hwang SI; Lee HJ; Byun SS; Lee SE; Hong SK
    PLoS One; 2018; 13(6):e0199636. PubMed ID: 29933396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Diffusion Kurtosis Imaging Versus Standard Diffusion Imaging for Detection and Grading of Peripheral Zone Prostate Cancer.
    Roethke MC; Kuder TA; Kuru TH; Fenchel M; Hadaschik BA; Laun FB; Schlemmer HP; Stieltjes B
    Invest Radiol; 2015 Aug; 50(8):483-9. PubMed ID: 25867657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transition zone prostate cancer: Logistic regression and machine-learning models of quantitative ADC, shape and texture features are highly accurate for diagnosis.
    Wu M; Krishna S; Thornhill RE; Flood TA; McInnes MDF; Schieda N
    J Magn Reson Imaging; 2019 Sep; 50(3):940-950. PubMed ID: 30701625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PI-RADS version 2: evaluation of diffusion-weighted imaging interpretation between b = 1000 and b = 1500 s mm
    Kwon MR; Kim CK; Kim JH
    Br J Radiol; 2017 Nov; 90(1079):20170438. PubMed ID: 28830221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fully automatic segmentation on prostate MR images based on cascaded fully convolution network.
    Zhu Y; Wei R; Gao G; Ding L; Zhang X; Wang X; Zhang J
    J Magn Reson Imaging; 2019 Apr; 49(4):1149-1156. PubMed ID: 30350434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiparametric MRI in detection and staging of prostate cancer.
    Boesen L
    Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of different computed high b-values on diffusion weighted imaging scores in Prostate Imaging Reporting and Data System version 2 of prostate cancer in peripheral zone].
    Wang W; Shao ZH; Zeng JQ; Wu DL; Wang GL; Wang PJ
    Zhonghua Yi Xue Za Zhi; 2017 Nov; 97(43):3401-3405. PubMed ID: 29179281
    [No Abstract]   [Full Text] [Related]  

  • 20. Diagnostic performance of PI-RADS version 2.1 compared to version 2.0 for detection of peripheral and transition zone prostate cancer.
    Rudolph MM; Baur ADJ; Cash H; Haas M; Mahjoub S; Hartenstein A; Hamm CA; Beetz NL; Konietschke F; Hamm B; Asbach P; Penzkofer T
    Sci Rep; 2020 Sep; 10(1):15982. PubMed ID: 32994502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.